# OnCo record select-lenvatinib (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/select-lenvatinib/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "select-lenvatinib", "NCT01321554" ;
  schema:name "SELECT"@en ;
  schema:description "Turned lenvatinib into the main drug for thyroid cancers that no longer take up radioactive iodine, quadrupling the time before the disease grew."@en ;
  schema:url <https://onco.cc/trials/select-lenvatinib/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01321554>, <https://www.nejm.org/doi/full/10.1056/NEJMoa1406470> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2011-03-17" ;
  onco:cancers <https://onco.cc/cancers/thyroid/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/>, <https://onco.cc/technologies/antiangiogenic/> ;
  onco:targets <https://onco.cc/targets/vegf/>, <https://onco.cc/targets/ret/> ;
  onco:companies <https://onco.cc/companies/eisai/> ;
  onco:terms <https://onco.cc/terms/rai-refractory/> ;
  onco:people <https://onco.cc/people/martin-schlumberger/> .